Soluble pattern recognition: pentraxins, collectins, ficolins
- Molecule
Some innate receptors float in blood and lung fluid: they coat microbes and dead cells so phagocytes and complement can deal with them.
What it is
Plasma and tissue fluids carry soluble proteins that recognise microbial and dead-cell patterns. Pentraxins (C-reactive protein, serum amyloid P, PTX3) bind phosphorylcholine and other surface molecules; collectins (mannose-binding lectin, surfactant proteins A and D) and ficolins bind sugars. They act as opsonins and start the classical or lectin complement pathways. C-reactive protein is the everyday lab marker of inflammation.
Key facts
- C1q, the first protein of the classical pathway, has the same collagen-tail-plus-head design as the collectins.
- CRP rises within hours of inflammation and falls quickly; it is made in the liver in response to IL-6.
- Surfactant proteins B and C handle surface tension; A and D are the immune (collectin) ones.
- Serum amyloid A, a different acute-phase protein, is the precursor of AA amyloid in chronic inflammation.
Step by step
- Infection or tissue injury makes macrophages release IL-6, together with IL-1 and TNF.
- IL-6 reaches the liver, where hepatocytes switch on CRP, MBL and other acute-phase proteins.
- CRP rises within hours and binds phosphorylcholine on bacteria and dying cells.
- Bound CRP activates C1q (classical pathway) and coats the target for phagocytes.
- When the stimulus ends CRP falls within days, which makes it useful for following treatment.
Soluble pattern-recognition molecules
| Family | Members | Made by | Binds | Effect |
|---|---|---|---|---|
| Short pentraxins | C-reactive protein (CRP), serum amyloid P | Liver, driven by IL-6 | Phosphorylcholine on bacteria and dying cells | Opsonisation; binds C1q → classical pathway |
| Long pentraxin | PTX3 | Macrophages, endothelium, dendritic cells at the site | Fungi, some bacteria and viruses | Local opsonin and complement activator |
| Collectins | Mannose-binding lectin (MBL) | Liver (acute-phase) | Mannose and N-acetylglucosamine on microbes | MASPs → lectin pathway of complement |
| Lung collectins | Surfactant proteins A and D | Type II pneumocytes, airway club cells | Microbial sugars in the alveoli | Aggregate and opsonise microbes for alveolar macrophages |
| Ficolins | Ficolin-1, -2, -3 | Liver, leukocytes | Acetylated sugars on bacteria | MASPs → lectin pathway |
Clinical notes
- MBL deficiency is common and usually mild, but can add infection risk in infants or with chemotherapy.
- A rising CRP helps follow bacterial infection or flares; it is non-specific and does not tell the cause.
- IL-6 blockade (tocilizumab) suppresses CRP, so CRP can stay low despite infection in treated patients.
Common traps
- A normal CRP rules out infection: patients on IL-6 blockade (tocilizumab) or with severe liver failure may not make CRP despite serious infection.
- CRP tells you the cause of inflammation: it is non-specific and rises with bacterial infection, flares, trauma and surgery alike.
- All surfactant proteins are immune molecules: only SP-A and SP-D are collectins, while SP-B and SP-C lower surface tension.
- Serum amyloid P and serum amyloid A are the same protein: SAP is a pentraxin found in all amyloid deposits; SAA is the precursor of AA amyloid.
- MBL deficiency is a severe immunodeficiency: it is common and usually silent, adding risk mainly in infancy or during chemotherapy.
Test yourself
Think of the answer, then tap the question to see it.
A patient on tocilizumab has fever and pneumonia, but CRP is normal. Why?
CRP is made by the liver in response to IL-6; blocking the IL-6 receptor prevents its rise, so a normal CRP cannot exclude infection.
Which complement pathway do MBL and ficolins activate, and through which enzymes?
The lectin pathway, through MBL-associated serine proteases (MASPs).
Why is C1q grouped with the collectins although it belongs to the classical pathway?
It shares their design, a collagen-like tail with globular recognition heads, and like MBL it triggers complement when its heads bind a target.
Elsewhere in DurgiPedia
Connections
In Pharmacology1
Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.
Sources: C-Reactive Protein (CRP) Test (MedlinePlus, US National Library of Medicine, 2025); Immune response (MedlinePlus, US National Library of Medicine, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
